Literature DB >> 3942499

Muramyl dipeptide enhances survival from experimental peritonitis.

G L Brown, H Foshee, J Pietsch, H C Polk.   

Abstract

Muramyl dipeptide is a nonspecific immunostimulant derived from Freund's complete adjuvant. We determined the effect of muramyl dipeptide on two separate animal models for peritonitis. We found that administration of muramyl dipeptide to rats undergoing cecal ligation and puncture significantly reduced mortality. Similarly, mice that underwent cecal ligation alone with muramyl dipeptide administration also had a statistically significant reduction in mortality compared with untreated controls.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3942499     DOI: 10.1001/archsurg.1986.01400010053006

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  3 in total

1.  Free versus liposome-encapsulated muramyl tripeptide phosphatidylethanolamide in treatment of experimental Klebsiella pneumoniae infection.

Authors:  P M Melissen; W van Vianen; Y Rijsbergen; I A Bakker-Woudenberg
Journal:  Infect Immun       Date:  1992-01       Impact factor: 3.441

2.  Fecal peritonitis: microbial adherence to serosal mesothelium and resistance to peritoneal lavage.

Authors:  C E Edmiston; M P Goheen; S Kornhall; F E Jones; R E Condon
Journal:  World J Surg       Date:  1990 Mar-Apr       Impact factor: 3.352

3.  Anti-infectious activity of liposomal muramyl dipeptides in immunodeficient CBA/N mice.

Authors:  N C Phillips; L Chedid
Journal:  Infect Immun       Date:  1987-06       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.